Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022. Issue 6 (8th June 2022)

• Record Type: Journal Article
• Authors: Weng, Mark K.; Doshani, Mona; Khan, Mohammed A.; Frey, Sharon; Ault, Kevin; Moore, Kelly L.; Hall, Eric W.; Morgan, Rebecca L.; Campos‐Outcalt, Doug; Wester, Carolyn; Nelson, Noele P.
• Is Part Of: American journal of transplantation. Volume 22:Issue 6(2022)
• Page Start: 1714
• Page End: 1720
• Publication Date: 2022-06-08
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/ajt.16661
• Languages: English
• ISSNs: 1600-6135

Abstract

Abstract : This article describes updates to the recommendations for hepatitis B vaccination in the US. Most notably, the Advisory Committee on Immunization Practices (ACIP) now recommends universal hepatitis B vaccination for all adults (without a history of hepatitis B infection) aged 19‐59 years, as well as those 60 and older with known risk factors for hepatitis B such as liver disease. Thus, all transplant candidates and recipients aged 19‐59 years, and all adult liver transplant candidates regardless of age, should be vaccinated for hepatitis B. Universal hepatitis B vaccination is already recommended for children.